

211. Nat Microbiol. 2021 Jan;6(1):73-86. doi: 10.1038/s41564-020-00841-4. Epub 2020
Dec 18.

Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques,
baboons and marmosets.

Singh DK(1)(2), Singh B(1)(2), Ganatra SR(1)(2), Gazi M(2), Cole J(1)(2),
Thippeshappa R(1)(2), Alfson KJ(2), Clemmons E(1)(2), Gonzalez O(1)(2), Escobedo 
R(1)(2), Lee TH(1)(2), Chatterjee A(1)(2), Goez-Gazi Y(2), Sharan R(1)(2), Gough 
M(1)(2), Alvarez C(1)(2), Blakley A(1)(2), Ferdin J(1)(2), Bartley C(1)(2),
Staples H(1)(2), Parodi L(1)(2), Callery J(1)(2), Mannino A(1)(2), Klaffke B(2), 
Escareno P(2), Platt RN 2nd(2), Hodara V(1)(2), Scordo J(2), Gautam S(2),
Vilanova AG(2), Olmo-Fontanez A(2), Schami A(2), Oyejide A(3), Ajithdoss DK(3),
Copin R(3), Baum A(3), Kyratsous C(3), Alvarez X(1)(2), Ahmed M(4), Rosa B(4),
Goodroe A(1)(2), Dutton J(1)(2), Hall-Ursone S(1)(2), Frost PA(1)(2), Voges
AK(1)(2)(5), Ross CN(1)(2), Sayers K(1)(2), Chen C(1)(2), Hallam C(2), Khader
SA(4), Mitreva M(4), Anderson TJC(2), Martinez-Sobrido L(2), Patterson JL(2),
Turner J(2), Torrelles JB(2), Dick EJ Jr(1)(2), Brasky K(1)(2), Schlesinger
LS(1)(2), Giavedoni LD(6)(7), Carrion R Jr(8)(9), Kaushal D(10)(11).

Author information: 
(1)Southwest National Primate Research Center, San Antonio, TX, USA.
(2)Texas Biomedical Research Institute, San Antonio, TX, USA.
(3)Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
(4)Washington University School of Medicine in St Louis, St Louis, MO, USA.
(5)Veterinary Imaging Consulting of South Texas, San Antonio, TX, USA.
(6)Southwest National Primate Research Center, San Antonio, TX, USA.
lgiavedoni@txbiomed.org.
(7)Texas Biomedical Research Institute, San Antonio, TX, USA.
lgiavedoni@txbiomed.org.
(8)Southwest National Primate Research Center, San Antonio, TX, USA.
rcarrion@txbiomed.org.
(9)Texas Biomedical Research Institute, San Antonio, TX, USA.
rcarrion@txbiomed.org.
(10)Southwest National Primate Research Center, San Antonio, TX, USA.
dkaushal@txbiomed.org.
(11)Texas Biomedical Research Institute, San Antonio, TX, USA.
dkaushal@txbiomed.org.

Erratum in
    Nat Microbiol. 2021 Mar;6(3):413.

Comment in
    Lab Anim (NY). 2021 Feb;50(2):44.

Non-human primate models will expedite therapeutics and vaccines for coronavirus 
disease 2019 (COVID-19) to clinical trials. Here, we compare acute severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in young and old rhesus
macaques, baboons and old marmosets. Macaques had clinical signs of viral
infection, mild to moderate pneumonitis and extra-pulmonary pathologies, and both
age groups recovered in two weeks. Baboons had prolonged viral RNA shedding and
substantially more lung inflammation compared with macaques. Inflammation in
bronchoalveolar lavage was increased in old versus young baboons. Using
techniques including computed tomography imaging, immunophenotyping, and
alveolar/peripheral cytokine response and immunohistochemical analyses, we
delineated cellular immune responses to SARS-CoV-2 infection in macaque and
baboon lungs, including innate and adaptive immune cells and a prominent type-I
interferon response. Macaques developed T-cell memory phenotypes/responses and
bystander cytokine production. Old macaques had lower titres of
SARS-CoV-2-specific IgG antibody levels compared with young macaques. Acute
respiratory distress in macaques and baboons recapitulates the progression of
COVID-19 in humans, making them suitable as models to test vaccines and
therapies.

DOI: 10.1038/s41564-020-00841-4 
PMCID: PMC7890948
PMID: 33340034  [Indexed for MEDLINE]

